<PAGE>
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 8, 1996
ROBERTS PHARMACEUTICAL CORPORATION
-----------------------------------------------------------------
(exact name of registrant as specified in its charter)
NEW JERSEY 1-1-432 22-2429994
------------------- ------------ --------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
-----------------------------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: 908-389-1182
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
-----------------------------------------------------------------
(Former name or former address, if changed from last report)
<PAGE>
-2-
Item 5. Other Events
------------
Roberts Pharmaceutical Corporation announced today that
shareholders, at a special meeting and by approximately 95% of votes cast,
approved the following proposals:
1. The issuance to the holders of the Company's 5% Convertible Preferred
Stock, $.10 par value per share of the full number of shares of the Company's
Common Stock, $.01 par value per share to which such holders are entitled upon
conversion of the 5% Preferred Stock; and
2. An amendment to the Company's Amended and Restated Certificate of
Incorporation which increases the authorized shares of the Company's Common
Stock, from 50,000,000 shares to 100,000,000 shares.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ROBERTS PHARMACEUTICAL CORPORATION
----------------------------------
(Registrant)
Date: November 13, 1996 By: /s/ Anthony A. Rascio
------------------------------
Anthony A. Rascio
Vice President
